Quick Answer
ENDONOVO THERAPEUTICS, INC. reported Stockholders Equity of -$32.18 million for fiscal year 2022.
ENDONOVO THERAPEUTICS, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2022 | -$32.18M | -104.0% |
| 2021 | -$15.77M | -9.7% |
| 2020 | -$14.37M | +29.9% |
| 2019 | -$20.50M | -80.0% |
| 2018 | -$11.39M | -19.3% |
| 2017 | -$9.55M | -11.5% |
| 2016 | -$8.56M | +7.7% |
| 2015 | -$9.28M | -97.7% |
| 2014 | -$4.69M | -13.6% |
| 2013 | -$4.13M | -5842.2% |
| 2011 | $72.0K | -56.7% |
| 2010 | $166.1K | -29.5% |
| 2009 | $235.4K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2023 | -$22.96M | -17.1% | -2.4% |
| June 30, 2023 | -$22.41M | -17.0% | +8.0% |
| March 31, 2023 | -$24.37M | -35.1% | +24.3% |
| December 31, 2022 | -$32.18M | -104.0% | -64.1% |
| September 30, 2022 | -$19.61M | -7.6% | -2.3% |
| June 30, 2022 | -$19.16M | -12.8% | -6.2% |
| March 31, 2022 | -$18.04M | -12.9% | -14.3% |
| December 31, 2021 | -$15.77M | -9.7% | +13.4% |
- ENDONOVO THERAPEUTICS, INC. showed a decrease of -104.0% in Stockholders Equity compared to the prior fiscal year.
- Over the 2009–2022 period, ENDONOVO THERAPEUTICS, INC.’s stockholders equity has declined by 13767.6% (from $235.4 thousand to -$32.18 million).
- The most recent figure is from ENDONOVO THERAPEUTICS, INC.’s fiscal year 2022 report (Form 10-K), filed with the SEC on April 17, 2023.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: